Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

Gainers Biofrontera Inc. (NASDAQ: BFRI) surged 39% to $6.02. Biofrontera announced Notice of Allowance for U.S. patent titled 'Illumination for Photodynamic Therapy.'...

40 Stocks Moving In Thursday's Mid-Day Session

December 02, 2021

Via Benzinga

Topics Intellectual Property

Tuesday Markets Review

November 30, 2021

The oil price did not fall as expected over the White House release of 50 mn bbls of oil.

Gainers Longeveron Inc. (NASDAQ: LGVN) shares surged 181.2% to settle at $28.20 on Monday on continued upward momentum after the company last week announced the FDA granted Rare...

61 Biggest Movers From Yesterday

November 23, 2021

Via Benzinga

Mid-Afternoon Market Update: Dow Rises 200 Points; Niu Technologies Shares Slide

November 22, 2021

Toward the end of trading Monday, the Dow traded up 0.59% to 35,811.07 while the NASDAQ fell 0.43% to 15,989.15. The S&P also rose, gaining 0.43% to 4,718.05. The U.S. has the...

Via Benzinga

Topics Stocks

Is An Aurinia Pharmaceuticals Buyout Coming? Why This Has Investors Doubting It

November 22, 2021

Aurinia tanked Monday as an SEC filing had investors questioning buyout rumors.

Via Investor's Business Daily

Topics Regulatory Compliance

Financial Stocks: WFC, MS, C, BAC, JPM and GS Gain on Powell Fed Chairman’s Second Term

November 22, 2021

Financial stocks are doing well on Monday thanks to an update from the U.S. Government concerning the next Federal Reserve chairman.

Aurinia Pharma (AUPH) stock is taking a beating on Monday following a filing with the SEC after markets closed on Friday.

Topics Economy

AUPH Stock: 13 Things to Know About Aurinia Pharma as Shares Crash Today

November 22, 2021

Midway through trading Monday, the Dow traded up 0.65% to 35,832.70 while the NASDAQ rose 0.67% to 16,164.51. The S&P also rose, gaining 0.87% to 4,738.91. The U.S. has the...

Topics Regulatory Compliance

Mid-Day Market Update: Gold Down 2%; iSpecimen Shares Spike Higher

November 22, 2021

Via Benzinga

Topics Stocks

40 Stocks Moving In Monday's Mid-Day Session

November 22, 2021

Gainers iSpecimen Inc. (NASDAQ: ISPC) shares climbed 126.5% to $11.12 after the company announced it has been contracted to support new advanced research on COVID-19 seeking...

Via Benzinga

Here's Why Aurinia Pharmaceuticals Is Falling Today

November 22, 2021

The company's recently filed unlimited shelf registration statement is making shareholders queasy.

Following the market opening Monday, the Dow traded up 0.77% to 35,876.58 while the NASDAQ rose 0.91% to 16,203.01. The S&P also rose, gaining 0.91% to 4,740.94. The U.S. has...

Mid-Morning Market Update: Markets Open Higher; Avaya Tops Q4 Views

November 22, 2021

Via Benzinga

Topics Stocks

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

November 22, 2021

Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday!

Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per...

20 Stocks Moving in Monday's Pre-Market Session

November 22, 2021

Via Benzinga

Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday

November 20, 2021

A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.

Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move?

November 06, 2021

It could be.

Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:

What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals

November 04, 2021

Via Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript

November 03, 2021

AUPH earnings call for the period ending September 30, 2021.

The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.

Topics Earnings

Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals

November 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...

Aurinia Pharmaceuticals: Q3 Earnings Insights

November 03, 2021

Via Benzinga

No Negative Reaction

October 28, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

Upgrades For Boot Barn Holdings Inc (NYSE:

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021

October 28, 2021

Via Benzinga

Cyber Currency

October 26, 2021

Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.

Aurinia stock hit another record Monday on Bristol's rumored takeover.

Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass?

October 25, 2021

Via Investor's Business Daily

55 Biggest Movers From Friday

October 25, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...

Via Benzinga

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today

October 22, 2021

The biotech is reportedly in buyout talks with Bristol Myers Squibb.

Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.

Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover

October 22, 2021

Via Investor's Business Daily

More Chinese Trouble

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

A Bit Of A Recovery

September 29, 2021